Argenx Se (ARGX) Common Equity (2015 - 2025)

Argenx Se (ARGX) posted Common Equity of $7.3 billion for Q4 2025, down 99.88% on a QoQ basis from $6095.8 billion in Q2 2025, and up 33.19% year-over-year from $5.5 billion in Q4 2024.

Argenx Se (ARGX) Common Equity (2015 - 2025) Analysis & Trends

Argenx Se's Common Equity history runs 11 years deep, the most recent figure standing at $7.3 billion for Q4 2025.

  • Quarterly Common Equity rose 33.19% year-over-year to $7.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.3 billion (up 33.19% YoY) and the FY2025 annual result came in at $7.3 billion, up 33.19% from the prior year.
  • Common Equity was $7.3 billion for Q4 2025 at Argenx Se, down from $6095.8 billion in the prior quarter.
  • Across five years, Common Equity topped out at $6095.8 billion in Q2 2025 and bottomed at $2.5 billion in Q4 2021.
  • A 5-year average of $613.1 billion and a median of $3.5 billion in 2022 frame the typical range for Common Equity.
  • Annual changes were most pronounced in 2023 — Common Equity dropped 3.78% — and 2025, when it jumped 142917.33%.
  • Argenx Se's Common Equity stood at $2.5 billion in 2021, then climbed by 11.03% to $2.8 billion in 2022, then soared by 45.63% to $4.1 billion in 2023, then jumped by 34.19% to $5.5 billion in 2024, then surged by 33.19% to $7.3 billion in 2025.
  • Business Quant data shows ARGX's Common Equity at $7.3 billion in Q4 2025, $6095.8 billion in Q2 2025, and $5.5 billion in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 251.12 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -98.34 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 14.38 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 4.76 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 795.79 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 1.50 Bn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 1.08 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 7.32 Bn
Jun 30, 2025 6,095.75 Bn
Dec 31, 2024 5.50 Bn
Jun 30, 2024 4.26 Bn
Dec 31, 2023 4.10 Bn
Jun 30, 2023 2.86 Bn
Dec 31, 2022 2.81 Bn
Jun 30, 2022 2.97 Bn
Dec 31, 2021 2.53 Bn
Jun 30, 2021 2.95 Bn
Dec 31, 2020 1.63 Bn
Jun 30, 2020 1.78 Bn
Dec 31, 2019 1.16 Bn
Jun 30, 2019 747.66 Mn
Dec 31, 2018 614.52 Mn
Jun 30, 2018 397.37 Mn
Dec 31, 2017 403.31 Mn
Jun 30, 2017 165.21 Mn
Dec 31, 2016 68.43 Mn
Dec 31, 2015 40.86 Mn